Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August-2019 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2019 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling

  • Authors:
    • Duzhen Zhang
    • Man Li
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1017-1024
    |
    Published online on: June 3, 2019
       https://doi.org/10.3892/mmr.2019.10320
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Puerarin is the major bioactive ingredient isolated from the dry root of Pueraria lobata, a plant used in traditional Chinese medicine. Puerarin has been used to treat diabetes and cataracts in China; however, its underlying mechanism of action remains unclear. The aim of the present study was to investigate the effectiveness and mechanism of puerarin in preventing cataracts in diabetic rats. Diabetes was induced by streptozocin (STZ) administration and rats were intraperitoneally injected with puerarin (25, 50 and 100 mg/kg). Blood glucose levels and cataract development were examined in the different experimental groups. In addition, the expression levels of markers associated with oxidative stress, including nuclear factor erythroid 2 like 2 (Nrf2) and heme oxygenase‑1 (HO‑1), were analyzed. The present results suggested that treatment with puerarin at 25, 50 and 100 mg/kg significantly reduced blood glucose levels and the incidence of cataract in STZ‑induced diabetic rats. Additionally, puerarin treatment reduced oxidative stress, restoring the levels of malondialdehyde and glutathione, and the activity of glutathione peroxidase. Furthermore, puerarin administration decreased the expression levels of retinal vascular endothelial growth factor and interleukin‑1β and increased the mRNA expression levels of Nrf2 and HO‑1, thus inhibiting oxidative stress. The present findings suggested that puerarin had hypoglycemic effects and that it prevented cataract development and progression in diabetic rats by reducing oxidative stress through the Nrf2/HO‑1 signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Sen S and Chakraborty R: Treatment and diagnosis of diabetes mellitus and its complication: Advanced approaches. Mini Rev Med Chem. 15:1132–1133. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Li L, Wan XH and Zhao GH: Meta-analysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol. 14:942014. View Article : Google Scholar : PubMed/NCBI

3 

Gardiner TA, Archer DB, Curtis TM and Stitt AW: Arteriolar involvement in the microvascular lesions of diabetic retinopathy: Implications for pathogenesis. Microcirculation. 14:25–38. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Javadi MA and Zareighanavati S: Cataracts in diabetic patients: A review article. J Ophthalmic Vis Res. 3:52–65. 2008.PubMed/NCBI

5 

Murphy P, Kabir MH, Srivastava T, Mason ME, Dewi CU, Lim S, Yang A, Djordjevic D, Killingsworth MC, Ho JWK, et al: Light-focusing human micro-lenses derived from zebrafish-like lens cell masses model lens development and drug-induced cataract in vitro. Development. 145(pii): dev1558382018.doi: 10.1242/dev.155838. View Article : Google Scholar : PubMed/NCBI

6 

Chua J, Koh JY, Tan AG, Zhao W, Lamoureux E, Mitchell P, Wang JJ, Wong TY and Cheng CY: Ancestry, socioeconomic status, and age-related cataract in asians: The Singapore epidemiology of eye diseases study. Ophthalmology. 122:2169–2178. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Head KA: Natural therapies for ocular disorders, part two: Cataracts and glaucoma. Altern Med Rev. 6:141–166. 2001.PubMed/NCBI

8 

Ross WM, Creighton MO and Trevithick JR: Radiation cataractogenesis induced by neutron or gamma irradiation in the rat lens is reduced by vitamin E. Scanning Microsc. 4:641–650. 1990.PubMed/NCBI

9 

Brown L, Rimm EB, Seddon JM, Giovannucci EL, Chasan-Taber L, Spiegelman D, Willett WC and Hankinson SE: A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr. 70:517–524. 1999. View Article : Google Scholar : PubMed/NCBI

10 

Varma SD, Kumar S and Richards RD: Light-induced damage to ocular lens cation pump: Prevention by vitamin C. Proc Natl Acad Sci USA. 76:3504–3506. 1979. View Article : Google Scholar : PubMed/NCBI

11 

Zhou YX, Zhang H and Peng C: Puerarin: A review of pharmacological effects. Phytother Res. 28:961–975. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Xie RQ, Du J and Hao YM: Myocardial protection and mechanism of puerarin injection on patients of coronary heart disease with ischemia/reperfusion. Zhongguo Zhong Xi Yi Jie He Za Zhi. 23:895–897. 2003.(In Chinese). PubMed/NCBI

13 

Jiang K, Chen H, Tang K, Guan W, Zhou H, Guo X, Chen Z, Ye Z and Xu H: Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway. Oncol Lett. 15:167–174. 2018.PubMed/NCBI

14 

Lorenzen J, Kumarswamy R, Dangwal S and Thum T: MicroRNAs in diabetes and diabetes-associated complications. RNA Biol. 9:820–827. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Zhao CY, Hou LH and Che HX: Influence of puerarin eye drops for the optic disc parameters and antioxidant capacity of patients with glaucoma. Int Eye Sci. 15:1332–1334. 2015.

16 

Liu CM, Ma JQ, Liu SS, Feng ZJ and Wang AM: Puerarin protects mouse liver against nickel-induced oxidative stress and inflammation associated with the TLR4/p38/CREB pathway. Chem Biol Interact. 243:29–34. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Ma JQ, Ding J, Xiao ZH and Liu CM: Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway. Food Chem Toxicol. 71:264–271. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Jun-Hua L, Zhang SP and Cong-Rong YU: Effect of puerarin on blood pressure and serum lipid in a rat model of insulin resistance. Chin J Pathophysiol. 22:997–1000. 2006.(In Chinese).

19 

Chen WC, Hayakawa S, Yamamoto T, Su HC, Liu IM and Cheng JT: Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 70:113–116. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Hao LN, Ling YL, Zhen-Yong GU, Huang XL and Shou-Zhi HE: Effects of puerarin on inducible nitric oxide synthase in lens during diabetic cataract in rats. Chin J Pathophysiol. 4:620–626. 2004.

21 

Qu L, Chen H, Liu X, Bi L, Xiong J, Mao Z and Li Y: Protective effects of flavonoids against oxidative stress induced by simulated microgravity in SH-SY5Y cells. Neurochem Res. 35:1445–1454. 2010. View Article : Google Scholar : PubMed/NCBI

22 

Rong L, Yang XD, Chen LJ, Wang AQ and He LF: New research progresses on and mechanism pharmacological effects of puerarin. Popular Sci Technol. 16:138–142. 2014.

23 

Hao LN, Wang M, Ma JL and Yang T: Puerarin decreases apoptosis of retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression. Sheng Li Xue Bao. 64:199–206. 2012.PubMed/NCBI

24 

Hao LN, He SZ, Shen YH, Zhang YQ, Wang ZY and Wang YH: Protective effects of puerarin on lens epithelial cells in rat diabetic cataract. Zhonghua Yan Ke Za Zhi. 47:320–326. 2011.(In Chinese). PubMed/NCBI

25 

Teng Y, Cui H, Yang M, Song H, Zhang Q, Su Y and Zheng J: Protective effect of puerarin on diabetic retinopathy in rats. Mol Biol Rep. 36:1129–1133. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Yuan W, Pan QI, Chen G, Yan J, Xia J and Chen Y: E-cadherin expression in a rat model of acute pancreatitis. Exp Ther Med. 10:2088–2092. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Dang M, Zeng X, Wang H, Li H, Du F, Chen B and Guo C: GW28-e0833 Inhibition of myocardial ischemia/reperfusion apoptosis by soluble receptor for advanced glycation end-product (sRAGE) via interferon-induced immunoproteasome activity. J Am Coll Cardiol. 70:C31–C32. 2017. View Article : Google Scholar

28 

Park JH, Lee YJ, Kim JJ, Shin YC and Kim JC: The effect of pinitol on cataractogenesis and anti-oxidative effect in streptozotocin induced diabetic rats. J Korean Ophthalmol Soc. 46:1886–1893. 2005.

29 

Xiaojian G, Qiuyan Z and Shuhua T: Inhibitory effect of r-hirudin variant III on streptozotocin-induced diabetic cataracts in rats. Scientific World J. 2013:6306512013.

30 

Arnal E, Miranda M, Almansa I, Muriach M, Barcia JM, Romero FJ, Diaz-Llopis M and Bosch-Morell F: Lutein prevents cataract development and progression in diabetic rats. Graefes Arch Clin Exp Ophthalmol. 247:115–120. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Yao XJ, Yin JA, Xia YF, Xia YF, Wei ZF, Luo YB, Liu M, Feleder C and Dai Y: Puerarin exerts antipyretic effect on lipopolysaccharide-induced fever in rats involving inhibition of pyrogen production from macrophages. J Ethnopharmacol. 141:322–330. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Zhao SS, Yang WN, Jin H, Ma KG and Feng GF: Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. Neurotoxicology. 51:166–171. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Varma SD: Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr. 53 (Suppl 1):S335–S345. 1991. View Article : Google Scholar

34 

Kowluru RA and Kanwar M: Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond). 4:82007. View Article : Google Scholar : PubMed/NCBI

35 

Zelinová V, Mistrík I, Pavlovkin J and Tamás L: Glutathione peroxidase expression and activity in barley root tip after short-term treatment with cadmium, hydrogen peroxide and t-butyl hydroperoxide. Protoplasma. 250:1057–1065. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

37 

Sun W, Zheng XZ, Xu QL, Nian H and Liu GL: Effects of puerarin on ADRP gene expression in fatty tissue of type 2 diabetes mellitus rats. Zhongguo Zhong Yao Za Zhi. 33:2026–2028. 2008.(In Chinese). PubMed/NCBI

38 

Hao LN, Ling YQ, Luo XM, Mao YX, Mao QY, He SZ and Ling YL: Puerarin decreases lens epithelium cell apoptosis induced partly by peroxynitrite in diabetic rats. Sheng Li Xue Bao. 58:584–592. 2006.PubMed/NCBI

39 

Wan L, Liu WB, Shen YY, Yu QL and Zhang JJ: Oxidative stress-apoptosis mediated STZ-induced diabetic cataract and the interventions of puerarin. Int J Ophthalmol. 14:1773–1775. 2014.

40 

Xu X, Zheng N, Chen Z, Huang W, Liang T and Kuang H: Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. Gene. 591:411–416. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Cai Y, Zhang X, Xu X and Yu Y: Effects of puerarin on the retina and STAT3 expression in diabetic rats. Exp Ther Med. 14:5480–5484. 2017.PubMed/NCBI

42 

Babizhayev MA, Vishnyakova KS and Yegorov YE: Telomere-dependent senescent phenotype of lens epithelial cells as a biological marker of aging and cataractogenesis: The role of oxidative stress intensity and specific mechanism of phospholipid hydroperoxide toxicity in lens and aqueous. Fundam Clin Pharmacol. 25:139–162. 2011. View Article : Google Scholar : PubMed/NCBI

43 

Katta AV, Katkam RV and Geetha H: Lipid peroxidation and the total antioxidant status in the pathogenesis of age related and diabetic cataracts: A study on the lens and blood. J Clin Diagn Res. 7:978–981. 2013.PubMed/NCBI

44 

Li S, Yue J, Zhou W and Li L: An investigation into the preparation, characterization and antioxidant activity of puerarin/cyclodextrin inclusion complexes. J Inclusion Phenomena Macrocyclic Chem. 82:1–8. 2015. View Article : Google Scholar

45 

Cui X, Gong J, Han H, He L, Teng Y, Tetley T, Sinharay R, Chung KF, Islam T, Gilliland F, et al: Relationship between free and total malondialdehyde, a well-established marker of oxidative stress, in various types of human biospecimens. J Thorac Dis. 10:3088–3097. 2018. View Article : Google Scholar : PubMed/NCBI

46 

Kamegawa M, Nakanishi-Ueda T, Iwai S, Ueda T, Kosuge S, Ogura H, Sasuga K, Inagaki M, Watanabe M, Oguchi K, et al: Effect of lipid-hydroperoxide-induced oxidative stress on vitamin E, ascorbate and glutathione in the rabbit retina. Ophthalmic Res. 39:49–54. 2007. View Article : Google Scholar : PubMed/NCBI

47 

Gologorsky D, Thanos A and Vavvas D: Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm. 2012:6294522012. View Article : Google Scholar : PubMed/NCBI

48 

Abdul Nasir NA, Agarwal R, Sheikh Abdul Kadir SH, Vasudevan S, Tripathy M, Iezhitsa I, Mohammad Daher A, Ibrahim MI and Mohd Ismail N: Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats. PLoS One. 12:e01745422017. View Article : Google Scholar : PubMed/NCBI

49 

Levari R, Wertheimer E, Berman ER and Kornblueth W: Effect of insulin on pathways of glucose oxidation in the rat lens. Nature. 192:1075–1076. 1961. View Article : Google Scholar : PubMed/NCBI

50 

Sabah JR, Davidson H, Mcconkey EN and Takemoto L: In vivo passage of albumin from the aqueous humor into the lens. Mol Vis. 10:254–259. 2004.PubMed/NCBI

51 

Drozdov AD and deClaville Christiansen J: Modeling the effects of pH and ionic strength on swelling of anionic polyelectrolyte gels. J Chem Phys. 142:1149042015. View Article : Google Scholar : PubMed/NCBI

52 

Feng CG, Zhang LX and Liu X: Progress in research of aldose reductase inhibitors in traditional medicinal herbs. Zhongguo Zhong Yao Za Zhi. 30:1496–1500. 2005.(In Chinese). PubMed/NCBI

53 

Kobayashi A, Ohta T and Yamamoto M: Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol. 378:273–286. 2004. View Article : Google Scholar : PubMed/NCBI

54 

Magesh S, Chen Y and Hu L: Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev. 32:687–726. 2012. View Article : Google Scholar : PubMed/NCBI

55 

Nakagami Y: Nrf2 is an attractive therapeutic target for retinal diseases. Oxid Med Cell Longev. 2016:74693262016. View Article : Google Scholar : PubMed/NCBI

56 

Foresti R, Bucolo C, Platania CM, Drago F, Dubois-Randé JL and Motterlini R: Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditions. Pharmacol Res. 99:296–307. 2015. View Article : Google Scholar : PubMed/NCBI

57 

Chen CY, Jang JH, Li MH and Surh YJ: Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun. 331:993–1000. 2005. View Article : Google Scholar : PubMed/NCBI

58 

Kim KC, Kang KA, Rui Z, Piao MJ, Kim GY, Kang MY, Lee SJ, Lee NH, Surh YJ and Hyun JW: Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt. Int J Biochem Cell Biol. 42:297–305. 2010. View Article : Google Scholar : PubMed/NCBI

59 

Finazzi D and Arosio P: Biology of ferritin in mammals: An update on iron storage, oxidative damage and neurodegeneration. Arch Toxicol. 88:1787–1802. 2014. View Article : Google Scholar : PubMed/NCBI

60 

Bucolo C and Drago F: Carbon monoxide and the eye: Implications for glaucoma therapy. Pharmacol Ther. 130:191–201. 2011. View Article : Google Scholar : PubMed/NCBI

61 

Zhou W, Yuan X, Zhang L, Su B, Tian D, Li Y, Zhao J, Wang Y and Peng S: Overexpression of HO-1 assisted PM2.5-induced apoptosis failure and autophagy-related cell necrosis. Ecotoxicol Environ Saf. 145:605–614. 2017. View Article : Google Scholar : PubMed/NCBI

62 

Lou J, Cao G, Li R, Liu J, Dong Z and Xu L: β-caryophyllene attenuates focal cerebral ischemia-reperfusion injury by Nrf2/HO-1 pathway in rats. Neurochem Res. 41:1291–1304. 2016. View Article : Google Scholar : PubMed/NCBI

63 

He M, Pan H, Chang RC, So KF, Brecha NC and Pu M: Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage. PLoS One. 9:e848002014. View Article : Google Scholar : PubMed/NCBI

64 

Yalniz M, Demirel U, Orhan C, Bahcecioglu IH, Ozercan IH, Aygun C, Tuzcu M and Sahin K: Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. Inflammation. 35:1213–1221. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang D and Li M: Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling. Mol Med Rep 20: 1017-1024, 2019.
APA
Zhang, D., & Li, M. (2019). Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling. Molecular Medicine Reports, 20, 1017-1024. https://doi.org/10.3892/mmr.2019.10320
MLA
Zhang, D., Li, M."Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling". Molecular Medicine Reports 20.2 (2019): 1017-1024.
Chicago
Zhang, D., Li, M."Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling". Molecular Medicine Reports 20, no. 2 (2019): 1017-1024. https://doi.org/10.3892/mmr.2019.10320
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang D and Li M: Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling. Mol Med Rep 20: 1017-1024, 2019.
APA
Zhang, D., & Li, M. (2019). Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling. Molecular Medicine Reports, 20, 1017-1024. https://doi.org/10.3892/mmr.2019.10320
MLA
Zhang, D., Li, M."Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling". Molecular Medicine Reports 20.2 (2019): 1017-1024.
Chicago
Zhang, D., Li, M."Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling". Molecular Medicine Reports 20, no. 2 (2019): 1017-1024. https://doi.org/10.3892/mmr.2019.10320
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team